To further elucidate the mechanism by which LIMD1 increases the sensitivity of lung adenocarcinoma cells to cisplatin, we detected the expression of GADD45α and constituents of the p38 MAPK signaling pathway. This evidence concerns the gene GADD45A and lung adenocarcinoma.